Prescribing to protect case series: naltrexone as a novel intervention to prevent fentanyl overdose in people who use cocaine.  Xue, R., Alves, J., Baldwin, M. et al. Addict Sci Clin Pract (2026). doi.org/10.1186/s13722-026-00701-2…

Long-Acting Naltrexone Restores Network Connectivity in Subjects With Comorbid Cannabis and Opioid Use Disorder.  Brier LM, Langleben DD, Wiers CE, Shi Z.  Addict Biol. 2026 May;31(5):e70159. doi: 10.1111/adb.70159. PMID: 42144806; PMCID…

Predictors of extended-release naltrexone adherence and relapse: Secondary outcomes from the MAT-PLUS pilot.  Thomas J., Wenzel K., Carrano J., Stidham J., Fishman M.:  Heroin Addict Relat Clin Probl. 28: 49–58, 2026. doi.org/1…

Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression.  Roberts E, Sanderson E…

Secondary analysis of a combined harm-reduction treatment and extended-release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth.  Goldstein SC, Weiss NH, Yang M, Feldst…

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV.  Appa A, Marti XL, Bara…